Seaton A, Seaton R A, Wightman A J
Department of Environmental & Occupational Medicine, University of Aberdeen, UK.
QJM. 1994 Sep;87(9):529-37.
Five non-smoking patients were diagnosed as having allergic bronchopulmonary aspergillosis in 1978/9. All have been treated since then with inhaled corticosteroids, using short courses of self-administered oral corticosteroids for symptomatic exacerbations. Over a mean 15 years of follow-up, they have required on average less than one course of oral drugs per annum. Regular monitoring of spirometry has shown no evidence of deterioration, and all have close to normal gas transfer. All have some localized bronchiectasis on CT scanning, in two cases probably occurring after treatment started, but in no case is there any respiratory disability. We conclude that this is a safe and effective method for the management of allergic bronchopulmonary aspergillosis when diagnosed before persistent hyphal colonization of the airways has occurred.
1978年或1979年,5名不吸烟患者被诊断为变应性支气管肺曲霉病。从那时起,他们均接受吸入性糖皮质激素治疗,症状加重时使用短期自行服用的口服糖皮质激素。经过平均15年的随访,他们平均每年需要的口服药物疗程少于1个。定期监测肺量计检查未发现病情恶化的迹象,所有患者的气体交换均接近正常。CT扫描显示所有患者均有一些局限性支气管扩张,其中2例可能在治疗开始后出现,但无一例出现呼吸功能障碍。我们得出结论,对于在气道出现持续性菌丝定植之前诊断出的变应性支气管肺曲霉病,这是一种安全有效的管理方法。